Literature DB >> 2591417

Metabolism of nafronyl in man.

K Roth1, M Hildebrand, K H Beyer.   

Abstract

The metabolism of nafronyl (I) has been studied in man. In addition to small amounts of the parent compound, three acidic metabolites were extracted from urine. The chemical structures of all metabolites were determined by using mass spectrometry and [1H]-NMR spectroscopy as tetrahydro-beta-(1-nephthalenylmethyl)-2-furanpropionic acid (II) and two stereoisomers of 3-(1-naphthalenylmethyl)-tetrahydrofuran-2-one-5-propionic acid (III, IV). The biodegradation products III and IV are formed after oxidation of the tetrahydrofuran system in II, hydrolytic ring opening of the gamma-butyrolacton and a subsequent formation of a gamma-butyrolacton ring with the second carboxyl group. The three metabolites represent the major fraction of unconjugated products in the urine of man after administration of nafronyl.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591417     DOI: 10.1007/BF03190853

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  5 in total

1.  [Pharmacologic value of a 1. cerebral cortex 2. tissue-pO2 recording technic in rabbits. Response to papaverine and naftidrofuryl].

Authors:  M Plotkine; C Z Paultre; R Boulu; P Rossignol
Journal:  Therapie       Date:  1975 Sep-Oct       Impact factor: 2.070

2.  [Effect of naftidrofuryl on cerebral energy metabolism in mice. 2nd part].

Authors:  A Meynaud; M Grand; M Belleville; L Fontaine
Journal:  Therapie       Date:  1975 Sep-Oct       Impact factor: 2.070

3.  [Naphydrefuryl, a peripheral vasidolator agent].

Authors:  A Sicard; A Mathivat; J J Welti; A Perrin; J Natali; A Ranglaret; R Cristol; L Fontaine; J Battino
Journal:  Presse Med       Date:  1968-04-27       Impact factor: 1.228

4.  [Some new naphthalenic structures with antispasmodic activity].

Authors:  E Szarvasi; M Bayssat; L Fontaine; M Grand
Journal:  Bull Soc Chim Fr       Date:  1966-06

5.  New approach to treatment of recent stroke.

Authors:  A K Admani
Journal:  Br Med J       Date:  1978-12-16
  5 in total
  1 in total

Review 1.  Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.

Authors:  L B Barradell; R N Brogden
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.